Cart
sales@molnova.com
Thalidomide-O-amido-C4-NH2 TFA
CAS No. 1799711-25-3
Thalidomide-O-amido-C4-NH2 TFA( Cereblon Ligand-Linker Conjugates 6 TFA | E3 ligase Ligand-Linker Conjugates 19 TFA )
Catalog No. M28568 CAS No. 1799711-25-3
Thalidomide-O-amido-C4-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 42 | In Stock |
|
| 5MG | 30 | In Stock |
|
| 10MG | 45 | In Stock |
|
| 25MG | 73 | In Stock |
|
| 50MG | 108 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameThalidomide-O-amido-C4-NH2 TFA
-
NoteResearch use only, not for human use.
-
Brief DescriptionThalidomide-O-amido-C4-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate.
-
DescriptionThalidomide-O-amido-C4-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate.
-
In Vitro——
-
In Vivo——
-
SynonymsCereblon Ligand-Linker Conjugates 6 TFA | E3 ligase Ligand-Linker Conjugates 19 TFA
-
PathwayOthers
-
TargetOther Targets
-
RecptorBacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1799711-25-3
-
Formula Weight516.43
-
Molecular FormulaC21H23F3N4O8
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 42.86 mg/mL (82.99 mM)
-
SMILESOC(=O)C(F)(F)F.NCCCCNC(=O)COc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rosenbaum, A.I., Rujoi, M., Huang, A.Y., et al. Chemical screen to reduce sterol accumulation in Niemann-Pick C disease cells identifies novel lysosomal acid lipase inhibitors. Biochim Biophys. Acta. 1791(12), 1155-1165 (2009).
molnova catalog
related products
-
FA-alkyne
FA-alkyne (FA alkyne) is a fluorescein that is a competitive probe for natural S-succinylation in FH-/- and FH+/+ cells and can be used to synthesize nanophotosensors.
-
Atracurium besylate
Atracurium besylate is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.
-
Physcion-8-O-tetragl...
Torososide B is an antiallergic compound that inhibits calcium ionophore A-induced leukotriene release from rat peritoneal mast cells.
